Synopsis
Synopsis
0
USDMF
0
CEP/COS
0
JDMF
0
EU WC
0
KDMF
0
NDC API
0
VMF
0
API
0
FDF
0
FDF Dossiers
0
FDA Orange Book
0
Europe
0
Canada
0
Australia
0
South Africa
0
Listed Dossiers
DRUG PRODUCT COMPOSITIONS
0
EDQM
0
USP
0
JP
0
Others
0
US Patents
0
US Exclusivities
0
Health Canada Patents
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
0
News #PharmaBuzz
US Medicaid
NA
Annual Reports
NA
Finished Drug Prices
NA
1. 32634-66-5
2. Di-p-toluoyl-l-tartaric Acid
3. (-)-di-p-toluoyl-l-tartaric Acid
4. (-)-o,o'-di-p-toluoyl-l-tartaric Acid
5. (2r,3r)-2,3-bis[(4-methylbenzoyl)oxy]butanedioic Acid
6. L-dtta
7. (-)-di-1,4-o-toluoyl-l-tartaric Acid
8. 2,3-bis[(4-methylbenzoyl)oxy]butanedioic Acid
9. L-(-)-di-p-toluoyltartaric Acid
10. 217968-14-4
11. Mfcd00064440
12. O,o'-di-p-toluoyl-l-tartaric Acid
13. L-ptta
14. (-)-di-1,4-toluoyl-l-tartaric Acid
15. (2r,3r)-2,3-bis[(4-methylbenzoyl)oxy]succinic Acid
16. Di-p-toluoyl-l-tartaricacid
17. Schembl72171
18. Butanedioic Acid, 2,3-bis[(4-methylbenzoyl)oxy]-, (2r,3r)-
19. Dtxsid20885538
20. L-(-di-p-toluoyl Tartaric Acid)
21. (-)-di-p-toluoyl-d-tartaric Acid
22. L-(-)-di-p-toluoyl-tartaric Acid
23. (-)-di-p-toluoyl-l-trataric Acid
24. Act03159
25. Zinc1592490
26. (-)-di-(p-toluoyl)-l-tartaric Acid
27. (?)-bis(p-toluoyl)-l-tartaric Acid
28. Akos016842466
29. (-)-di-1,4-o-toluoyl-ltartaric Acid
30. Ac-3432
31. Am81409
32. (-)-di-o,o'-p-toluoyl-l-tartaric Acid
33. As-12034
34. (-)-o,o'-di-1,4-toluoyl-l-tartaric Acid
35. Cs-0015300
36. D1387
37. L-(-)-tartaric Acid-o,o'-di-p-toluoyl Ester
38. (2r,3r)-(-)-di-o-4-toluoyl-l-tartaric Acid
39. 34d665
40. (-)-o,o'-di-p-toluoyl-l-tartaric Acid, 97%
41. (2r,3r)-2,3-bis(4-methylbenzoyloxy)succinic Acid
42. W-106833
43. F0001-0969
44. (-)-o,o'-di-p-toluoyl-l-tartaric Acid, Purum, >=98.0% (t)
45. (2r,3r)-(-)-2,3-bis[(4-methylbenzoyl)oxy]butane-1,4-dioic Acid
| Molecular Weight | 386.4 g/mol |
|---|---|
| Molecular Formula | C20H18O8 |
| XLogP3 | 3.3 |
| Hydrogen Bond Donor Count | 2 |
| Hydrogen Bond Acceptor Count | 8 |
| Rotatable Bond Count | 9 |
| Exact Mass | 386.10016753 g/mol |
| Monoisotopic Mass | 386.10016753 g/mol |
| Topological Polar Surface Area | 127 Ų |
| Heavy Atom Count | 28 |
| Formal Charge | 0 |
| Complexity | 533 |
| Isotope Atom Count | 0 |
| Defined Atom Stereocenter Count | 2 |
| Undefined Atom Stereocenter Count | 0 |
| Defined Bond Stereocenter Count | 0 |
| Undefined Bond Stereocenter Count | 0 |
| Covalently Bonded Unit Count | 1 |
ABOUT THIS PAGE
A Di-P-Toluoyl- L-Tartaric Acid manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Di-P-Toluoyl- L-Tartaric Acid, including repackagers and relabelers. The FDA regulates Di-P-Toluoyl- L-Tartaric Acid manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Di-P-Toluoyl- L-Tartaric Acid API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of Di-P-Toluoyl- L-Tartaric Acid manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.
A Di-P-Toluoyl- L-Tartaric Acid supplier is an individual or a company that provides Di-P-Toluoyl- L-Tartaric Acid active pharmaceutical ingredient (API) or Di-P-Toluoyl- L-Tartaric Acid finished formulations upon request. The Di-P-Toluoyl- L-Tartaric Acid suppliers may include Di-P-Toluoyl- L-Tartaric Acid API manufacturers, exporters, distributors and traders.
click here to find a list of Di-P-Toluoyl- L-Tartaric Acid suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
Di-P-Toluoyl- L-Tartaric Acid Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Di-P-Toluoyl- L-Tartaric Acid GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Di-P-Toluoyl- L-Tartaric Acid GMP manufacturer or Di-P-Toluoyl- L-Tartaric Acid GMP API supplier for your needs.
A Di-P-Toluoyl- L-Tartaric Acid CoA (Certificate of Analysis) is a formal document that attests to Di-P-Toluoyl- L-Tartaric Acid's compliance with Di-P-Toluoyl- L-Tartaric Acid specifications and serves as a tool for batch-level quality control.
Di-P-Toluoyl- L-Tartaric Acid CoA mostly includes findings from lab analyses of a specific batch. For each Di-P-Toluoyl- L-Tartaric Acid CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Di-P-Toluoyl- L-Tartaric Acid may be tested according to a variety of international standards, such as European Pharmacopoeia (Di-P-Toluoyl- L-Tartaric Acid EP), Di-P-Toluoyl- L-Tartaric Acid JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Di-P-Toluoyl- L-Tartaric Acid USP).
LOOKING FOR A SUPPLIER?
